Identification of Altered Plasma Proteins by Proteomic Study in Valvular Heart Diseases and the Potential Clinical Significance

被引:31
作者
Gao, Ge [1 ,2 ,3 ,4 ]
Xuan, Chao [5 ]
Yang, Qin [1 ,2 ,3 ,4 ,6 ]
Liu, Xiao-Cheng [5 ]
Liu, Zhi-Gang [5 ]
He, Guo-Wei [1 ,2 ,3 ,4 ,7 ]
机构
[1] Hangzhou Normal Univ, TEDA Int Cardiovasc Hosp, Tianjin, Peoples R China
[2] Hangzhou Normal Univ, Affiliated Hosp, Tianjin, Peoples R China
[3] Hangzhou Normal Univ, TEDA Int Cardiovasc Hosp, Hangzhou, Zhejiang, Peoples R China
[4] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China
[5] TEDA Int Cardiovasc Hosp, Tianjin, Peoples R China
[6] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[7] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA
基金
中国国家自然科学基金;
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; HUMAN AORTIC-STENOSIS; CARBONIC-ANHYDRASE; GEL-ELECTROPHORESIS; ATRIAL APPENDAGES; VALVE; TRANSFERRINS; COMPLEMENT; FIBRONECTIN; VITRONECTIN;
D O I
10.1371/journal.pone.0072111
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Little is known about genetic basis and proteomics in valvular heart disease (VHD) including rheumatic (RVD) and degenerative (DVD) valvular disease. The present proteomic study examined the hypothesis that certain proteins may be associated with the pathological changes in the plasma of VHD patients. Methods and Results: Differential protein analysis in the plasma identified 18 differentially expressed protein spots and 14 corresponding proteins or polypeptides by two-dimensional electrophoresis and mass spectrometry in 120 subjects. Two up-regulated (complement C4A and carbonic anhydrase 1) and three down-regulated proteins (serotransferrin, alpha-1-antichymotrypsin, and vitronectin) were validated by ELISA in enlarging samples. The plasma levels (n = 40 for each) of complement C4A in RVD (715.8 +/- 35.6 vs. 594.7 +/- 28.2 ng/ml, P = 0.009) and carbonic anhydrase 1 (237.70 +/- 15.7 vs. 184.7 +/- 10.8 U/L, P = 0.007) in DVD patients were significantly higher and that of serotransferrin (2.36 +/- 0.20 vs. 2.93 +/- 0.16 mg/ml, P = 0.025) and alpha-1-antichymotrypsin (370.0 +/- 13.7 vs. 413.0 +/- 11.6 mu g/ml, P = 0.019) in RVD patients were significantly lower than those in controls. The plasma vitronectin level in both RVD (281.3 +/- 11.0 vs. 323.2 +/- 10.0 mg/ml, P = 0.006) and DVD (283.6 +/- 11.4 vs. 323.2 +/- 10.0 mu g/ml, P = 0.011) was significantly lower than those in normal controls. Conclusions: We have for the first time identified alterations of 14 differential proteins or polypeptides in the plasma of patients with various VHD. The elevation of plasma complement C4A in RVD and carbonic anhydrase 1 in DVD and the decrease of serotransferrin and alpha-1-antichymotrypsin in RVD patients may be useful biomarkers for these valvular diseases. The decreased plasma level of vitronectin - a protein related to the formation of valvular structure - in both RVD and DVD patients might indicate the possible genetic deficiency in these patients.
引用
收藏
页数:9
相关论文
共 50 条
[1]   Transferrins selectively cause ion efflux through bacterial and artificial membranes [J].
Aguilera, O ;
Quiros, LM ;
Fierro, JF .
FEBS LETTERS, 2003, 548 (1-3) :5-10
[2]  
Aitken A., 2005, PROTEOMICS PROTOCOLS, P319, DOI DOI 10.1385/1-59259-890-0:319
[3]   Immunolocalization of elastin, collagen type I and type III, fibronectin, and vitronectin in extracellular matrix components of normal and myxomatous mitral heart valve chordae tendineae [J].
Akhtar, S ;
Meek, KM ;
James, V .
CARDIOVASCULAR PATHOLOGY, 1999, 8 (04) :203-211
[4]   The human plasma proteome - History, character, and diagnostic prospects [J].
Anderson, NL ;
Anderson, NG .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (11) :845-867
[5]   Antimicrobial Mechanism of Action of Transferrins: Selective Inhibition of H+ -ATPase [J].
Andres, Maria T. ;
Fierro, Jose F. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (10) :4335-4342
[6]   SERPINA3 (aka alpha-1-antichymotrypsin) [J].
Baker, Crystal ;
Belbin, Olivia ;
Kalsheker, Noor ;
Morgan, Kevin .
FRONTIERS IN BIOSCIENCE, 2007, 12 :2821-2835
[7]   Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4 [J].
Blanchong, CA ;
Chung, EK ;
Rupert, KL ;
Yang, Y ;
Yang, ZY ;
Zhou, B ;
Moulds, JM ;
Yu, CY .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (03) :365-392
[8]  
Bouchey D, 1996, ANAT RECORD, V244, P540
[9]   The global burden of group A streptococcal diseases [J].
Carapetis, JR ;
Steer, AC ;
Mulholland, EK ;
Weber, M .
LANCET INFECTIOUS DISEASES, 2005, 5 (11) :685-694
[10]  
Carter ND, 1991, CARBONIC ANHYDRASES, P197